N6-methyladenosine RNA modification: A promising regulator in central nervous system injury

Exp Neurol. 2021 Nov:345:113829. doi: 10.1016/j.expneurol.2021.113829. Epub 2021 Jul 31.

Abstract

In addition to DNA methylation, reversible epigenetic modification occurring in RNA has been discovered recently. The most abundant type of RNA methylation is N6-methyladenosine (m6A) modification, which is dynamically regulated by methylases ("writers"), demethylases ("erasers") and m6A-binding proteins ("readers"). As an essential posttranscriptional regulator, m6A can control mRNA splicing, processing, stability, export and translation. Recent studies have revealed that m6A modification has the strongest tissue specificity for brain tissue and plays crucial roles in central nervous system (CNS) injures by affecting its downstream target genes or non-coding RNAs. This review focuses on the expression and function of m6A regulatory proteins in CNS trauma in vitro and in vivo. We also highlight the latest insights into the molecular mechanisms of pathological damage in the CNS. Understanding m6A dynamics, functions, and machinery will yield an opportunity for designing and developing novel therapeutic agents for CNS injuries.

Keywords: Central nervous system injury; Epitranscriptomics; N6-methyladenosine; RNA modification.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / genetics
  • Adenosine / metabolism
  • Animals
  • Central Nervous System / injuries*
  • Central Nervous System / metabolism*
  • Epigenesis, Genetic / physiology*
  • Humans
  • RNA / genetics
  • RNA / metabolism*

Substances

  • RNA
  • N-methyladenosine
  • Adenosine